Healthcare IT & Genomics
Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, clinical trials/drug discovery and oncology informatics & diagnostics
Reports
Teleradiology - World - 2021
This is a proposal for a new Market Report on the global market for Teleradiology, to be published in April 2021.
Signify Premium Insights – Medical Imaging - 2021
Subscribers to Signify Premium Insights – Medical Imaging receive approximately 100 actionable and up to the moment Premium Insights per year.
High-Acuity and Perinatal IT - World - 2021
This is a proposal for a new Market Report on the global market for High-Acuity Care and Perinatal IT. The report examines the market for ICUIS, OR Manager, EDIS, Perinatal IT and AIMS.
Digital Pathology – World – 2020
This report provides a detailed, data-centric analysis of the market for Digital Pathology. Features include global and country-level market estimates and forecasts for 2017-2024.
Oncology IT - World - 2021
This is a proposal for Signify Research’s 2020 report on the global market for oncology IT to be published in May 2021.
AI in Drug Development & Clinical Trials - World - 2020
This is a brochure for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials published in November 2020.
Analyst Insights
Signify Premium Insight: The Options for Watson
Signify Premium Insights Subscription Required
March 2nd 2021 – IBM, and its plan to use AI to solve some of the biggest problems in healthcare, made headlines when it first announced its Watson Health division. Now however, the company is reportedly looking to sell the unit. This insight considers what’s changed to assess the rumours.
Signify Premium Insight: Intelerad Acquires LumedX – Now the Work Begins
Signify Premium Insights Subscription Required
February 25th 2021 – News broke last week that imaging IT vendor Intelerad has acquired LumedX, the latest in a rapid-fire acquisition streak from the imaging IT vendor, In this Insight we analyse the implications of the acquisition for the firms and postulate to the drivers and market context that have led to the deal.
Are EMR-based Oncology Modules Threatening Best-of-Breed Oncology IT?
18th February 2021 – With several EMR vendors now marketing their own Oncology-specific modules, healthcare providers will be deciding between best-of-breed and EMR-based offerings; so how this will affect the existing Oncology Information System (OIS) market, and how will incumbent vendors respond to the challenge?
Signify Premium Insight: Volpara Acquires CRA Health in $22m Deal
Signify Premium Insights Subscription Required
11th February 2021 – Breast health company Volpara has revealed it has acquired breast cancer risk assessment company, CRA Health in a deal worth $22m. In this Insight, we explore the motivations and potential impacts of the deal.
Signify Premium Insight: COVID-19’s Impact on the Imaging IT Market
Signify Premium Insights Subscription Required
9th February 2021 – The imaging IT market has not been immune to the impact of the COVID-19 pandemic. This insight explains how the market has been affected, as well as how vendors can best react to the changing conditions.